Cart
Compound Libraries Approved / Repurposing

Approved / Repurposing

There are five libraries in this category: Approved Drug Library, Clinical Compound Library, Drug Repurposing Library, FDA-Approved Drug Library, and Preclinical Compound Library. The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.

Cat No. product name
L1000 Approved Drug Library A unique collection of 2342 approved drugs for high throughput screening (HTS) and high content screening (HCS); 2342 compounds
L3400 Clinical Compound Library A unique collection of 1487 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); 1487 compounds
L4200 FDA-approved Drug Library A unique collection of 1436 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); 1436 compounds
L3410 Preclinical Compound Library A unique collection of 450 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); 450 compounds
L9200 Drug Repurposing Library A unique collection of 3216 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); 3216 compounds
L1010 FDA Approved & Pharmacopeial Drug Library 2950 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); 2950 compounds
Approved Drug Library
L1000 compounds - 2342
Clinical Compound Library
L3400 compounds - 1487
FDA-approved Drug Library
L4200 compounds - 1436
Preclinical Compound Library
L3410 compounds - 450
Drug Repurposing Library
L9200 compounds - 3216
FDA Approved & Pharmacopeial Drug Library
L1010 compounds - 2950